Copyright
©The Author(s) 2023.
World J Gastroenterol. Aug 7, 2023; 29(29): 4542-4556
Published online Aug 7, 2023. doi: 10.3748/wjg.v29.i29.4542
Published online Aug 7, 2023. doi: 10.3748/wjg.v29.i29.4542
Figure 7 Effect of miR-204-3p on the MAPK signaling pathway in AGS and HGC-27 cells.
A and B: Effects of miR-204-3p on mRNA levels of KRAS, ERK1 and ERK2 in AGS and HGC-27 cells; C and D: Effects of miR-204-3p on protein levels of KRAS, ERK1/2 and p-ERK1/2 in AGS cells; E and F: Effects of miR-204-3p on protein levels of KRAS, ERK1/2 and p-ERK1/2 in HGC-27 cells. aP < 0.05, bP < 0.01, cP < 0.001. NC: Empty lentiviral vector; KD: miR-204-3p knockdown lentiviral vector; OE: miR-204-3p overexpression lentiviral vector.
- Citation: Li X, Tibenda JJ, Nan Y, Huang SC, Ning N, Chen GQ, Du YH, Yang YT, Meng FD, Yuan L. MiR-204-3p overexpression inhibits gastric carcinoma cell proliferation by inhibiting the MAPK pathway and RIP1/MLK1 necroptosis pathway to promote apoptosis. World J Gastroenterol 2023; 29(29): 4542-4556
- URL: https://www.wjgnet.com/1007-9327/full/v29/i29/4542.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i29.4542